Beyond Air (XAIR)
(Real Time Quote from BATS)
$1.27 USD
+0.07 (5.83%)
Updated May 16, 2024 02:06 PM ET
2-Buy of 5 2
F Value D Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Beyond Air, Inc. [XAIR]
Reports for Purchase
Showing records 1 - 20 ( 54 total )
Company: Beyond Air, Inc.
Industry: Medical - Drugs
We are updating our Healthcare coverage to reflect a recent analyst departure and to drop
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Beyond Air, Inc.
Industry: Medical - Drugs
Company: Beyond Air, Inc.
Industry: Medical - Drugs
Company: Beyond Air, Inc.
Industry: Medical - Drugs
Company: Beyond Air, Inc.
Industry: Medical - Drugs
Company: Beyond Air, Inc.
Industry: Medical - Drugs
Company: Beyond Air, Inc.
Industry: Medical - Drugs
Company: Beyond Air, Inc.
Industry: Medical - Drugs
Company: Beyond Air, Inc.
Industry: Medical - Drugs
Company: Beyond Air, Inc.
Industry: Medical - Drugs
FY2Q23 Recap - Launch in Progress; Cardiac Indication a Differentiator
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Beyond Air, Inc.
Industry: Medical - Drugs
Company: Beyond Air, Inc.
Industry: Medical - Drugs
Our Inaugural Healthcare Opportunities Conference in New York City on October 6th
Provider: Roth Capital Partners, Inc.
Analyst: PIROS E
Company: Beyond Air, Inc.
Industry: Medical - Drugs
Company: Beyond Air, Inc.
Industry: Medical - Drugs
FY1Q23 - Launch Underway; Cardiac Indication Could Add to Differentiation
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Beyond Air, Inc.
Industry: Medical - Drugs
Company: Beyond Air, Inc.
Industry: Medical - Drugs
FY4Q22 Recap - Approval In Hand; Launch Imminent
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S